Stryker Corp. (SYK)
318.13
+5.05
(+1.61%)
USD |
NYSE |
Nov 20, 10:10
Stryker Cash from Operations (Quarterly) : 1.461B for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.461B |
| June 30, 2026 | 1.261B |
| March 31, 2026 | 581.00M |
| December 31, 2025 | 2.143B |
| September 30, 2025 | 1.54B |
| June 30, 2025 | 1.111B |
| March 31, 2025 | 250.00M |
| December 31, 2024 | 1.931B |
| September 30, 2024 | 1.474B |
| June 30, 2024 | 633.00M |
| March 31, 2024 | 204.00M |
| December 31, 2023 | 1.528B |
| September 30, 2023 | 1.05B |
| June 30, 2023 | 688.00M |
| March 31, 2023 | 445.00M |
| December 31, 2022 | 1.003B |
| September 30, 2022 | 889.00M |
| June 30, 2022 | 529.00M |
| March 31, 2022 | 203.00M |
| December 31, 2021 | 1.00B |
| September 30, 2021 | 933.00M |
| June 30, 2021 | 878.00M |
| March 31, 2021 | 452.00M |
| December 31, 2020 | 1.237B |
| September 30, 2020 | 829.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 620.00M |
| March 31, 2020 | 591.00M |
| December 31, 2019 | 735.00M |
| September 30, 2019 | 629.00M |
| June 30, 2019 | 514.00M |
| March 31, 2019 | 313.00M |
| December 31, 2018 | 1.046B |
| September 30, 2018 | 618.00M |
| June 30, 2018 | 649.00M |
| March 31, 2018 | 297.00M |
| December 31, 2017 | 679.00M |
| September 30, 2017 | 79.00M |
| June 30, 2017 | 650.00M |
| March 31, 2017 | 151.00M |
| December 31, 2016 | 751.00M |
| September 30, 2016 | 493.00M |
| June 30, 2016 | 468.00M |
| March 31, 2016 | 203.00M |
| December 31, 2015 | 671.00M |
| September 30, 2015 | -509.00M |
| June 30, 2015 | 357.00M |
| March 31, 2015 | 380.00M |
| December 31, 2014 | 675.00M |
| September 30, 2014 | 535.00M |
| June 30, 2014 | 366.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 1.224B |
| Zimmer Biomet Holdings, Inc. | 560.00M |
| Becton, Dickinson & Co. | 1.458B |
| Boston Scientific Corp. | 1.048B |
| Globus Medical, Inc. | 265.23M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -187.00M |
| Cash from Financing (Quarterly) | -1.393B |
| Free Cash Flow | 4.573B |
| Free Cash Flow Per Share (Quarterly) | 3.182 |
| Free Cash Flow to Equity (Quarterly) | 1.237B |
| Free Cash Flow to Firm (Quarterly) | 1.332B |
| Free Cash Flow Yield | 3.78% |